Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica : A Prospective Multicenter Study
OBJECTIVE: To assess the performance of the new 2012 provisional European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) polymyalgia rheumatica (PMR) clinical classification criteria in discriminating PMR from other mimicking conditions compared with the previous 5 diagnostic criteria in a multicenter prospective study.
METHODS: Patients older than 50 years, presenting with new-onset bilateral shoulder pain with elevated acute-phase reactants (APR), were assessed for the fulfillment of the new and old classification/diagnostic criteria sets for PMR. At the end of the 1-year followup, 133 patients were diagnosed with PMR (expert opinion) and 142 with non-PMR conditions [69 rheumatoid arthritis (RA)]. Discriminating capacity, sensitivity, and specificity of the criteria sets were estimated.
RESULTS: Discriminating capacity of the new clinical criteria for PMR from non-PMR conditions and RA as estimated by area under the curve (AUC) were good with AUC of 0.736 and 0.781, respectively. The new criteria had a sensitivity of 89.5% and a specificity of 57.7% when tested against all non-PMR cases. When tested against all RA, seropositive RA, seronegative RA, and non-RA control patients, specificity changed to 66.7%, 100%, 20.7%, and 49.3%, respectively. Except for the Bird criteria, the 4 previous criteria had lower sensitivity and higher specificity (ranging from 83%-93%) compared with the new clinical criteria in discriminating PMR from all other controls.
CONCLUSION: The new 2012 EULAR/ACR clinical classification criteria for PMR is highly sensitive; however, its ability to discriminate PMR from other inflammatory/noninflammatory shoulder conditions, especially from seronegative RA, is not adequate. Imaging and other modifications such as cutoff values for APR might increase the specificity of the criteria.
Errataetall: |
CommentIn: J Rheumatol. 2016 May;43(5):836-8. - PMID 27134265 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
The Journal of rheumatology - 43(2016), 5 vom: 01. Mai, Seite 893-900 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ozen, Gulsen [VerfasserIn] |
---|
Links: |
---|
Themen: |
CLASSIFICATION CRITERIA |
---|
Anmerkungen: |
Date Completed 07.12.2017 Date Revised 19.04.2022 published: Print-Electronic CommentIn: J Rheumatol. 2016 May;43(5):836-8. - PMID 27134265 Citation Status MEDLINE |
---|
doi: |
10.3899/jrheum.151103 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM257064834 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM257064834 | ||
003 | DE-627 | ||
005 | 20231224182015.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3899/jrheum.151103 |2 doi | |
028 | 5 | 2 | |a pubmed24n0856.xml |
035 | |a (DE-627)NLM257064834 | ||
035 | |a (NLM)26834222 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ozen, Gulsen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica |b A Prospective Multicenter Study |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.12.2017 | ||
500 | |a Date Revised 19.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: J Rheumatol. 2016 May;43(5):836-8. - PMID 27134265 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To assess the performance of the new 2012 provisional European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) polymyalgia rheumatica (PMR) clinical classification criteria in discriminating PMR from other mimicking conditions compared with the previous 5 diagnostic criteria in a multicenter prospective study | ||
520 | |a METHODS: Patients older than 50 years, presenting with new-onset bilateral shoulder pain with elevated acute-phase reactants (APR), were assessed for the fulfillment of the new and old classification/diagnostic criteria sets for PMR. At the end of the 1-year followup, 133 patients were diagnosed with PMR (expert opinion) and 142 with non-PMR conditions [69 rheumatoid arthritis (RA)]. Discriminating capacity, sensitivity, and specificity of the criteria sets were estimated | ||
520 | |a RESULTS: Discriminating capacity of the new clinical criteria for PMR from non-PMR conditions and RA as estimated by area under the curve (AUC) were good with AUC of 0.736 and 0.781, respectively. The new criteria had a sensitivity of 89.5% and a specificity of 57.7% when tested against all non-PMR cases. When tested against all RA, seropositive RA, seronegative RA, and non-RA control patients, specificity changed to 66.7%, 100%, 20.7%, and 49.3%, respectively. Except for the Bird criteria, the 4 previous criteria had lower sensitivity and higher specificity (ranging from 83%-93%) compared with the new clinical criteria in discriminating PMR from all other controls | ||
520 | |a CONCLUSION: The new 2012 EULAR/ACR clinical classification criteria for PMR is highly sensitive; however, its ability to discriminate PMR from other inflammatory/noninflammatory shoulder conditions, especially from seronegative RA, is not adequate. Imaging and other modifications such as cutoff values for APR might increase the specificity of the criteria | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a CLASSIFICATION CRITERIA | |
650 | 4 | |a POLYMYALGIA RHEUMATICA | |
650 | 4 | |a RHEUMATOID ARTHRITIS | |
700 | 1 | |a Inanc, Nevsun |e verfasserin |4 aut | |
700 | 1 | |a Unal, Ali Ugur |e verfasserin |4 aut | |
700 | 1 | |a Bas, Seda |e verfasserin |4 aut | |
700 | 1 | |a Kimyon, Gezmis |e verfasserin |4 aut | |
700 | 1 | |a Kisacik, Bunyamin |e verfasserin |4 aut | |
700 | 1 | |a Onat, Ahmet Mesut |e verfasserin |4 aut | |
700 | 1 | |a Murat, Sadiye |e verfasserin |4 aut | |
700 | 1 | |a Keskin, Havva |e verfasserin |4 aut | |
700 | 1 | |a Can, Meryem |e verfasserin |4 aut | |
700 | 1 | |a Mengi, Alperen |e verfasserin |4 aut | |
700 | 1 | |a Cakir, Necati |e verfasserin |4 aut | |
700 | 1 | |a Balkarli, Ayse |e verfasserin |4 aut | |
700 | 1 | |a Cobankara, Veli |e verfasserin |4 aut | |
700 | 1 | |a Yilmaz, Neslihan |e verfasserin |4 aut | |
700 | 1 | |a Yazici, Ayten |e verfasserin |4 aut | |
700 | 1 | |a Dogru, Atalay |e verfasserin |4 aut | |
700 | 1 | |a Sahin, Mehmet |e verfasserin |4 aut | |
700 | 1 | |a Sahin, Ali |e verfasserin |4 aut | |
700 | 1 | |a Gok, Kevser |e verfasserin |4 aut | |
700 | 1 | |a Senel, Soner |e verfasserin |4 aut | |
700 | 1 | |a Pamuk, Omer Nuri |e verfasserin |4 aut | |
700 | 1 | |a Yilmaz, Sema |e verfasserin |4 aut | |
700 | 1 | |a Bayindir, Ozun |e verfasserin |4 aut | |
700 | 1 | |a Aksu, Kenan |e verfasserin |4 aut | |
700 | 1 | |a Cagatay, Yonca |e verfasserin |4 aut | |
700 | 1 | |a Akyol, Lutfi |e verfasserin |4 aut | |
700 | 1 | |a Sayarlioglu, Mehmet |e verfasserin |4 aut | |
700 | 1 | |a Yildirim-Cetin, Gozde |e verfasserin |4 aut | |
700 | 1 | |a Yasar-Bilge, Sule |e verfasserin |4 aut | |
700 | 1 | |a Yagci, Ilker |e verfasserin |4 aut | |
700 | 1 | |a Aydin, Sibel Zehra |e verfasserin |4 aut | |
700 | 1 | |a Alibaz-Oner, Fatma |e verfasserin |4 aut | |
700 | 1 | |a Atagunduz, Pamir |e verfasserin |4 aut | |
700 | 1 | |a Direskeneli, Haner |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of rheumatology |d 1983 |g 43(2016), 5 vom: 01. Mai, Seite 893-900 |w (DE-627)NLM000019593 |x 1499-2752 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2016 |g number:5 |g day:01 |g month:05 |g pages:893-900 |
856 | 4 | 0 | |u http://dx.doi.org/10.3899/jrheum.151103 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2016 |e 5 |b 01 |c 05 |h 893-900 |